Cargando…
Clobazam‐treated patients with Lennox‐Gastaut syndrome experienced fewer seizure‐related injuries than placebo patients during trial OV‐1012
Drop seizures are especially problematic in patients with Lennox‐Gastaut syndrome (LGS) because of their potential for serious injury. In this post hoc analysis of phase 3 OV‐1012 data, a medical review was conducted of seizure‐related injuries based on Medical Dictionary for Regulatory Activities (...
Autores principales: | Isojarvi, Jouko, Lee, Deborah, Peng, Guangbin, Sperling, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5021111/ https://www.ncbi.nlm.nih.gov/pubmed/27145465 http://dx.doi.org/10.1111/epi.13388 |
Ejemplares similares
-
Stable dosages of clobazam for Lennox-Gastaut syndrome are associated with sustained drop-seizure and total-seizure improvements over 3 years
por: Conry, Joan A, et al.
Publicado: (2014) -
Clobazam as an adjunctive therapy in treating seizures associated with Lennox–Gastaut syndrome
por: Leahy, Jennifer T, et al.
Publicado: (2011) -
Comprehensive overview: efficacy, tolerability, and cost-effectiveness of clobazam in Lennox–Gastaut syndrome
por: Faulkner, Michele A
Publicado: (2015) -
Use and cost comparison of clobazam to other antiepileptic drugs for treatment of Lennox-Gastaut syndrome
por: François, Clément, et al.
Publicado: (2017) -
The Curious Case of Lennox-Gastaut Syndrome: Treatment-Resistant Seizures in a Patient With Autism Spectrum Disease With Lennox-Gastaut Syndrome
por: Anvekar, Priyanka, et al.
Publicado: (2021)